Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 |
|---|---|---|---|---|---|
| Research and development | 267,240 | 943,478 | 1M | 2M | 1M |
| Selling, general and administrative | 1M | 886,055 | 2M | 596,886 | 328,995 |
| Operating expenses | 2M | 2M | 4M | 3M | 3M |
| Operating income | −2M | −2M | −4M | −3M | −3M |
| Net income | −2M | −2M | −4M | −3M | −4M |
| Earnings per share | −0.43 | −1.05 | −3.29 | −0.30 | −39.83 |
| Earnings per share, diluted | −0.43 | −1.05 | −3.29 | −0.30 | −39.83 |
| Weighted average shares | 5M | 2M | 1M | 10M | 95,004 |
| Weighted average shares, diluted | 5M | 2M | 1M | 10M | 95,004 |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1M | 334,005 | 2M | 5M | 5M | 2M | 156,656 | — |
| Current assets | 2M | 502,911 |
| Metric | 31/03/2026 | 31/03/2025 |
|---|---|---|
| Operating cash flow | −2M | −3M |
| Depreciation and amortisation | 633,340 | 1,008 |
| Share-based compensation | 35,018 | 537,046 |
| Investing cash flow | −36,000 | — |
| Financing cash flow | 3M | 5M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3M |
| 5M |
| 5M |
| 2M |
| 361,351 |
| — |
| Property, plant and equipment | 16,311 | 17,319 | 18,327 | 19,335 | 18,356 | 19,364 | 21,160 | — |
| Total assets | 12M | 10M | 4M | 6M | 5M | 3M | 673,568 | — |
| Current liabilities | 8M | 8M | 2M | 2M | 2M | 2M | 2M | — |
| Total liabilities | 8M | 8M | 2M | 2M | 2M | 2M | 2M | — |
| Equity | 3M | 2M | 1M | 4M | 3M | 709,152 | −1M | — |
| Shares outstanding | 6M | 2M | 1M | 1M | 6M | 163,093 | 3M | 2M |
| Shares issued | 6M | 2M | 1M | 1M | 6M | 163,093 | 3M | 2M |